NASH: Concurrent Fibrosis and Fat Imaging and Quantification
In the particular case of NAFLD and NASH, we concurrently acquire SHG (collagen) and 2PE (tissue morphometrics and inflammation) images from the same unstained FFPE section, which is returned undamaged for further molecular pathology tests if needed.
Full method presented at Keystone Fibrosis and Inflammation, 2017. See publications.
Our image Analysis tools concurrently quantify fibrosis and Microvesicular Steatosis: we count and stratification of microvesicular features extracted on the 2PE images. Vascular features (also "round and dark") are excluded as they are surrounded by collagen (identified by SHG) and often contain internal 2PE fluorescent from hemoglobin. We are currently developing software to also quantify ballooning and Inflammation. In 2017, both Fibrosis and the NAS-activity score can potentially become fully automated. Subscribe here if you are interested to stay informed of our progress.
In this case Study (Fat Diet NASH Mouse model N=4, vs Drug A and Drug B candidates, N=4) we highlight the combined efficacy of the drug candidates as anti-steatotic and and-fibrotic compounds. Dots are the group averages. Our method uses ONE FFPE slide to derive all the information. Turnaround time is les than 2 weeks for a typical 4 arms x 4 animals study.
We are developing image Analysis tools to automatically quantify Lobular Inflammation and Ballooning from the same images used to quantify fibrosis and Steatosis. While the the method is still experimental, we welcome investigator-initiated studies.